October 14, 2021

IFF joins EuropaBio: Applying Science and Creativity for a Better World

EuropaBio is pleased to announce that IFF has joined the association as a corporate member.
October 14, 2021

EuropaBio sat down with new Member IFF, to find out about their focus on health and well-being, product performance, and user satisfaction

EuropaBio sat down with new Member to find out about their focus on health and well-being, product performance, and user satisfaction.
September 30, 2021

Artificial intelligence: investing in new technologies in healthcare

What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?
September 8, 2021

Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

July 29, 2021

EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’

July 22, 2021

Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites

June 29, 2021

EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes

EuropaBio is pleased to announce that EV Biotech has joined the organization as an Associate Member.
June 23, 2021

Interview with… Dr. Jernej Pintar, CEO and Head of Tech Community at Technology Park Ljubljana

EuropaBio sat down with new Member Technology Park Ljubljana, to find out about their journey from creation in 1994.
June 23, 2021

Technology Park Ljubljana joins EuropaBio: better world through better technology

EuropaBio is pleased to announce that Technology Park Ljubljana has joined the organization as part of the National Associations Council.
June 14, 2021

Novartis is proud to support the EuropaBio 25th Anniversary

EuropaBio is delighted to announce that Novartis has joined EuropaBio’s 25th Anniversary Celebration Programme as a Sponsor.
June 9, 2021

Interview with Cyrille Pauthenier, CEO of Abolis Biotechnologies – The Bio-Synthesis Architects

EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
May 31, 2021

EuropaBio Key Messages to 94th Pharmaceutical Committee – 28 May 2021

May 20, 2021

EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments

May 20, 2021

Decentralised clinical trials, the future of clinical research

The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
May 19, 2021

EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open

EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open
Become a member